Cannabidiol science, marketing, and legal perspectives

Recent loosening of legal restrictions on cannabis and its chemical constituents, including phytocannabinoids such as Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), has led to rapid proliferation and wide availability of products containing CBD. Although using pure CBD does not result in THC-l...

Full description

Bibliographic Details
Main Authors: Wiley, Jenny L., Gourdet, Camille K. (Author), Thomas, Brian F. (Author)
Corporate Author: RTI International
Format: eBook
Language:English
Published: Research Triangle Park, NC RTI Press 2020, April 2020
Series:Occasional paper
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02070nam a2200265 u 4500
001 EB002001681
003 EBX01000000000000001164582
005 00000000000000.0
007 tu|||||||||||||||||||||
008 210907 r ||| eng
100 1 |a Wiley, Jenny L. 
245 0 0 |a Cannabidiol  |h Elektronische Ressource  |b science, marketing, and legal perspectives  |c Jenny L. Wiley, Camille K. Gourdet, and Brian F. Thomas 
260 |a Research Triangle Park, NC  |b RTI Press  |c 2020, April 2020 
300 |a 1 PDF file (ii,16 pages)  |b illustrations 
505 0 |a Includes bibliographical references 
700 1 |a Gourdet, Camille K.  |e [author] 
700 1 |a Thomas, Brian F.  |e [author] 
710 2 |a RTI International 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Occasional paper 
500 |a "RTI Press publication OP-0065-2004." 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK565434  |3 Volltext 
082 0 |a 610 
520 |a Recent loosening of legal restrictions on cannabis and its chemical constituents, including phytocannabinoids such as Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD), has led to rapid proliferation and wide availability of products containing CBD. Although using pure CBD does not result in THC-like intoxication, it is not risk-free. In this review, we examine CBD from scientific, marketing, and regulatory perspectives. Specifically, we evaluate the evidence used to support statements concerning CBD's real and putative medical effects and discuss misleading information that has been used in marketing approaches. Also, we explore the current legal landscape surrounding CBD. We conclude that further research is necessary to clarify legitimate therapeutic effects of CBD. Federal regulation is also necessary to assure quality, safety, and efficacy of CBD products. Until new regulations are enacted to ensure purity and label accuracy, consumers should balance any perceived benefits of CBD use against potential risks associated with using products of unknown quality